Edition:
United Kingdom

Nate Raymond

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

12:41am BST

Minnesota hospitals wins challenge to Medicaid payment rule

A federal appeals court on Monday struck down a 2010 policy adopted by the U.S. Centers for Medicare & Medicaid Services that altered how Medicaid payments to hospitals that treat high numbers of low-income patients are calculated.

20 Aug 2018

Smith & Nephew defeats lawsuit claiming it overcharged hospitals

A federal judge has dismissed a whistleblower lawsuit accusing medical device manufacturer Smith & Nephew of defrauding government-run hospitals by overcharging them for the expedited delivery of equipment and supplies.

18 Aug 2018

Drug distributor Miami-Luken loses appeal of quashed DEA subpoena

Miami-Luken Inc on Friday lost an appeal of a decision by the former head of the U.S. Drug Enforcement Administration to quash an administrative subpoena requiring the agency to turn over records to the Ohio drug distributor as it fought to keep its license to dispense controlled substances.

17 Aug 2018

Linde's Lincare unit settle Medicare Advantage false claims case

Linde AG's Lincare unit has agreed to pay $5.25 million to resolve allegations that it offered illegal price reductions to patients covered by Medicare Advantage plans in connection with the purchase of home oxygen equipment and supplies.

17 Aug 2018

Ex-employee of pharmacy tied to meningitis outbreak pleads guilty

A former employee of a Massachusetts compounding pharmacy whose tainted drugs were at the center of a fungal meningitis outbreak that killed 76 people in 2012 pleaded guilty on Friday and agreed to testify against his coworkers.

17 Aug 2018

Air ambulance pricing dispute preempted by federal law - 8th Circuit

By Nate Raymond A federal appeals court on Thursday upheld the dismissal of a proposed class action lawsuit claiming that an air ambulance operator owned by Air Medical Group Holdings Inc improperly conceals how much it plans to charge to transport patients to hospitals. The 8th U.S. Circuit Court of Appeals in St. Louis ruled that state law claims pursued by Arkansas resident James Ferrell on behalf other patients transported by Air EVAC EMS Inc are preempted by the federal Airline Deregulation Act (ADA) of 1978. To read the full story on WestlawNext Practitioner Insights, click here: http://bit.ly/2vQbYTA

17 Aug 2018

Exclusive: OxyContin maker Purdue taps financial restructuring adviser - sources

NEW YORK/BOSTON OxyContin maker Purdue Pharma LP has tapped law firm Davis Polk & Wardwell LLP for financial restructuring advice, as its potential liabilities swell with a wave of lawsuits over the opioid addiction epidemic sweeping the United States, people familiar with the matter said on Thursday.

16 Aug 2018

U.S. judge bars retrial of ex-Georgeson employees in bribe case

BOSTON A federal judge on Thursday ruled prosecutors could not retry three former employees of a firm that advises companies on shareholder votes who were accused of using bribes to learn how a proxy advisory firm's investor clients voted.

16 Aug 2018

UPDATE 2-U.S. judge bars retrial of ex-Georgeson employees in bribe case

BOSTON, Aug 16 A federal judge on Thursday ruled prosecutors could not retry three former employees of a firm that advises companies on shareholder votes who were accused of using bribes to learn how a proxy advisory firm's investor clients voted.

16 Aug 2018

Opioid maker Insys in talks to settle New York lawsuit

Insys Therapeutics Inc is engaged in talks to settle a lawsuit by New York's attorney general seeking at least $75 million over allegations it recklessly promoted a fentanyl-based cancer pain medicine for much wider uses and bribed doctors to prescribe it.

  • Europe
  • U.S.
  • Asia
  • Sectors
Stock Search
FTSE 100 7,568.72 -22.54 -0.30%
DAX 12,372.77 + 41.47 +0.34%
CAC 40 5,416.97 + 37.32 +0.69%
TR Europe 176.54 + 1.82 +1.04%
GBP/USD 1.2868 +0.56%
GBP/EUR 1.1162 +0.17%
EUR/USD 1.1527 +0.42%
Gold 1,190.50 +3.70 +0.31%
Oil 67.71 +1.28 +1.93%
Corn 362.25 +0.25 +0.07%